Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2012
11/29/2012US20120302530 23-hydroxy-betulinic acid derivatives, preparation methods and uses thereof
11/29/2012US20120302527 C7-Fluoro Substituted Tetracycline Compounds
11/29/2012US20120302522 Synergistic antiviral composition and use thereof
11/29/2012US20120302519 Multiple substituted fluoromethanes as selective and bioactive isosteres
11/29/2012US20120302518 Polymorphic Form Of N-(S)-(3,4-Difluoro-2-(2-Fluoro-4-Iodophenylamino)-6-Methoxyphenyl)-1-(2,3-Dihydroxypropyl)Cyclopropane-1-Sulfonamide And Uses Thereof
11/29/2012US20120302494 Synergistic combinations of polyene fungicides and non-ribosomal peptides and related methods of use
11/29/2012US20120302493 Cyclic Peptides As G-Protein Coupled Receptor Antagonists
11/29/2012US20120301527 Hair follicle targeting compositions
11/29/2012US20120301515 Anti-adhesion material
11/29/2012US20120301514 Development of bioactive electrospun coatings for biomedical applications
11/29/2012US20120301508 Compositions for Induction of Osteogenesis around an Implant
11/29/2012US20120301504 Influenza Virus Recombinant Proteins
11/29/2012US20120301503 Influenza hemagglutinin and neuraminidase variants
11/29/2012US20120301502 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
11/29/2012US20120301501 Method for selecting and producing vaccine components and vaccines based thereon
11/29/2012US20120301499 Packaging of Immunostimulatory Substances into Virus-Like Particles: Method of Preparation and Use
11/29/2012US20120301496 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
11/29/2012US20120301495 Antigen peptide and use thereof
11/29/2012US20120301494 Proteolysis-resistant capsid of chimeric hepatitis e virus as an oral delivery vector
11/29/2012US20120301493 Applications of the protein muns and the derivates thereof
11/29/2012US20120301483 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c
11/29/2012US20120301481 Targeting poly-gamma-glutamic acid to treat staphylococcus epidermidis and related infections
11/29/2012US20120301480 H. pylori lipopolysaccharide outer core epitope
11/29/2012US20120301474 Compositions and methods for immunization against drug resistant acinetobacter baumannii
11/29/2012US20120301469 amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
11/29/2012US20120301466 Chemically programmable immunity
11/29/2012US20120301465 Compositions and methods to immunize against hepatitis c virus
11/29/2012US20120301457 LIPID COFACTORS FOR FACILITATING PROPOGATION OF PRPsc
11/29/2012US20120301449 Rna interference target for treating aids
11/29/2012US20120301446 Compositions and methods for re-programming cells without genetic modification for treatment of neurological disorders
11/29/2012US20120301435 Probiotic bifidobacterial composition in accordance with secretor blood group status
11/29/2012US20120301434 Antibacterial polypeptides and use thereof
11/29/2012US20120301430 Thiophene analogues for the treatment or prevention of flavivirus infections
11/29/2012US20120301428 Clostridium gene
11/29/2012US20120301427 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/29/2012US20120301422 Enhancement of the action of anti-infective agents and of central and peripheral nervous system agents and transportation of nucleic acid substances
11/29/2012US20120301408 Oral care methods and compositions utilizing chitosan-derivative compounds
11/29/2012US20120301407 Method of treating a mammalian teat and related compositions
11/29/2012US20120301403 Polyethylene glycolated superoxide dismutase mimetics
11/29/2012US20120301397 Diagnosis of macrophage mediated disease
11/29/2012CA2837126A1 Canine influenza recombinant virus, preparation method therefor and application thereof
11/29/2012CA2837079A1 Picolinamido-propanoic acid derivatives useful as glucagon receptor antagonists
11/29/2012CA2837027A1 4-aryl-n-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
11/29/2012CA2836131A1 Synergistic combinations of polyene fungicides and non-ribosomal peptides and related methods of use
11/29/2012CA2835755A1 Family of aryl, heteroaryl, o-aryl and o-heteroaryl carbasugars
11/29/2012CA2834862A1 Pharmaceutical composition for administration to nails
11/29/2012CA2834855A1 Topical pharmaceutical composition based on semifluorinated alkanes
11/29/2012CA2825333A1 Antagonism of the vip signaling pathway
11/28/2012EP2527445A2 Treatment and prevention of influenza
11/28/2012EP2527353A2 Caprazol derivatives
11/28/2012EP2527352A2 Caprazene derivatives
11/28/2012EP2527351A1 Lipophosphonoxins, method of their preparation and use
11/28/2012EP2527343A1 Heterocyclic compound having azole group
11/28/2012EP2527332A1 4-Aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group as CDK9 inhibitors
11/28/2012EP2527007A1 Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
11/28/2012EP2526972A1 A conjugate of an antibody against CD4 and antifusogenic peptides
11/28/2012EP2526965A1 Immunisation method against the 4 Dengue serotypes
11/28/2012EP2526964A1 Immunisation method against the 4 Dengue serotypes
11/28/2012EP2526110A1 Methods for producing amino-substituted glycolipid compounds
11/28/2012EP2526091A1 Derivatives of pyridoxine for inhibiting hiv integrase
11/28/2012EP2525818A2 Immunogenic influenza composition
11/28/2012CN202554516U Externally used medicine bag for treating liver disease
11/28/2012CN202554513U Physical antibacterial film for skin
11/28/2012CN1895671B Compound preparation for treating viral liver disease
11/28/2012CN1738829B New 2',5'-oligoadenylic acid analog
11/28/2012CN102803260A Substituted polycyclic carbamoylpyridone derivative
11/28/2012CN102803256A Method for preparing (r)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1h)-yl)phenyl)-5-(substituted methyl)oxazolidin-2-one derivatives
11/28/2012CN102803249A Hepatitis c virus inhibitors
11/28/2012CN102803237A Oxazole and thiazole derivatives as alx receptor agonists
11/28/2012CN102803232A Antifungal 1, 2, 4-triazolyl Derivatives Having A 5- Sulfur Substituent
11/28/2012CN102803231A Antifungal 1,2,4-triazolyl derivatives
11/28/2012CN102803230A Antifungal 1,2,4-triazolyl derivatives having a 5-sulfur substituent
11/28/2012CN102803226A Cycloalkyl-substituted imidazole derivative
11/28/2012CN102803224A Novel azabicyclohexanes
11/28/2012CN102803216A Heterocyclic antiviral compounds
11/28/2012CN102803211A High penetration compositions or prodrugs of antimicrobials and antimicrobial-related compounds
11/28/2012CN102802664A Immunogenic compositions
11/28/2012CN102802650A Antituberculosis compositions of byttneria species
11/28/2012CN102802648A Lactobacillus johnsonii La1 NCC533 (CNCM I-1225) and immune disorders
11/28/2012CN102802644A Mixtures of acids for use as antiviral agents
11/28/2012CN102796758A Recombinant porcine alpha interferon and application thereof in preparing medicines for treating Porcine cytomegalovirus (PCMV)
11/28/2012CN102796757A Carrier capable of showing and expressing helicobacter pylori protein on surface of lactococcus lactis, and preparation method and application of carrier
11/28/2012CN102796755A Lactococcus lactis expression vector and preparation method and application thereof
11/28/2012CN102796749A Epidemic encephalitis B/dengue chimeric virus with epidemic encephalitis B virus attenuated strain as gene framework and application of epidemic encephalitis B/dengue chimeric virus
11/28/2012CN102796734A Novel target for interfering EV71 as well as small interfering RNA (Ribose Nucleic Acid) and application thereof
11/28/2012CN102796710A Non-pathogenic recombinant attenuated rabies virus strain and construction method and application thereof
11/28/2012CN102796181A Peptide nucleic acid for porcine reproductive and respiratory syndrome virus and application of peptide nucleic acid
11/28/2012CN102796179A Template - fixed peptidomimetics with antimicrobial activity
11/28/2012CN102796176A Kunyuenin, preparation method and application
11/28/2012CN102796172A Hepatitis B virus (HBV) specific human leukocyte antigen-A33 (HLA-A33) restrictive epitope peptides and application thereof
11/28/2012CN102796157A Caudatin derivative and medicinal composition and application thereof
11/28/2012CN102796155A Nucleotide and oligonucleotide prodrugs
11/28/2012CN102796139A Phosphoramido pyridine derivative, and preparation method, medical composition and application thereof in antifungal agent
11/28/2012CN102796138A (2-(3-methylthio-1,2,4-thiadiazinyl)ethyoxyl)methyl phosphonate derivatives, and preparation and application thereof
11/28/2012CN102796125A Tazobactam ampicillin amide composite, its preparation method and application
11/28/2012CN102796119A Cefpirome sulfate compound and composition thereof
11/28/2012CN102796118A Cefodizime sodium compound solid, method for preparing same and pharmaceutical preparation of cefodizime sodium compound solid
11/28/2012CN102796087A Coumarin triadimenol, and preparation method and application thereof
11/28/2012CN102796085A Coumarin triazole, and preparation method and application thereof
11/28/2012CN102796084A Application of active substance to treatment of hepatitis C and preparation method thereof
1 ... 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 ... 1798